You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ampligen

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Post COVID-19 Condition, Long COVID Trial (Rintatolimod, Placebo / Normal Saline)

Not yet recruiting
  • Post COVID-19 Condition
  • Long COVID
  • (no location specified)
Oct 20, 2022

Pancreatic Cancer Trial (Rintatolimod)

Not yet recruiting
  • Pancreatic Cancer
  • (no location specified)
Aug 8, 2022

Chronic Fatigue Syndrome Trial in Incline Village, Charlotte (Poly I: Poly C12U (Rintatolimod))

Available
  • Chronic Fatigue Syndrome
  • Poly I: Poly C12U (Rintatolimod)
  • Incline Village, Nevada
  • +1 more
Apr 29, 2022

HIV Trial in Pittsburgh (Ampligen)

Completed
  • HIV Infections
  • Ampligen
  • Pittsburgh, Pennsylvania
    Univ of Pittsburgh Med School
Oct 27, 2021

HIV Trial in Washington, Hershey (Ampligen)

Completed
  • HIV Infections
  • Ampligen
  • Washington, District of Columbia
  • +1 more
Oct 27, 2021

Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Durvalumab
  • Rintatolimod
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Jun 23, 2023

Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)

Active, not recruiting
  • Triple -Negative Breast Cancer
  • +4 more
  • Biopsy
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 1, 2022

Ovarian Cancer Recurrent Trial in Pittsburgh (Rintatolimod, Pembrolizumab, Cisplatin)

Recruiting
  • Ovarian Cancer Recurrent
  • Pittsburgh, Pennsylvania
    Magee-Womens Hospital of UPMC
Mar 3, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Philadelphia (OC-L/Montanide ISA 51 VG, Ampligen,

Terminated
Has Results
  • Ovarian Cancer
  • +2 more
  • OC-L/Montanide ISA 51 VG
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Oct 18, 2021

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Best Practice
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 1, 2022

HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

Recruiting
  • HLA-A2 Positive Cells Present
  • Refractory Melanoma
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 12, 2022

Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,

Completed
Has Results
  • Metastatic Carcinoma in the Liver
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 25, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Biopsy
  • +7 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 23, 2023

Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors Trial in Pittsburgh (Chemokin Modulatory Regimen (5 MU/m2), Chemokin

Terminated
Has Results
  • Colorectal Cancer
  • +3 more
  • Chemokin Modulatory Regimen (5 MU/m2)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 21, 2020

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

Suspended
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +18 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2022

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Seattle (HER-2/neu peptide vaccine,

Completed
  • HER2-positive Breast Cancer
  • +7 more
  • HER-2/neu peptide vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 4, 2020

Malignant Tumor of Pancreas Metastatic to Peritoneal Surface, Malignant Peritoneal Mesothelioma, Peritoneal Carcinomatosis Trial

Completed
Has Results
  • Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface
  • +2 more
  • DC vaccine
  • +3 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 6, 2020

SARS-CoV-2 Infection, COVID-19 Trial in Derby (Remdesivir)

Not yet recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • Derby, United Kingdom
    University of Derby
Jun 21, 2023

Influenza, Human Trial in Birmingham (Poly I:Poly C12U 50 ug, Poly I:Poly C12U 200 ug, Poly I:Poly C12U 500 ug)

Terminated
  • Influenza, Human
  • Poly I:Poly C12U 50 ug
  • +5 more
  • Birmingham, Alabama
    The University of Alabama at Birmingham
Jul 23, 2018

Metastatic Colorectal Cancer Trial in Pittsburgh (aDC1 vaccine, CKM)

Withdrawn
  • Metastatic Colorectal Cancer
  • Pittsburgh, Pennsylvania
    Hillman Cancer Center
Sep 25, 2017

HIV-Associated Heart Disease

Completed
  • Cardiovascular Diseases
  • +4 more
    • (no location specified)
    Feb 17, 2016

    Chronic Fatigue Syndrome, Myalgic Encephalomyelitis Trial (Ampligen)

    Completed
    • Chronic Fatigue Syndrome
    • Myalgic Encephalomyelitis
    • Ampligen
    • (no location specified)
    Apr 16, 2013

    HIV Seropositivity, HIV Infection Trial in United States (poly I-poly C12U)

    Completed
    • HIV Seropositivity
    • HIV Infection
    • poly I-poly C12U
    • Fountain Valley, California
    • +9 more
    Apr 16, 2013

    HIV Seropositivity, HIV Infection Trial in United States (poly I-poly C12U)

    Terminated
    • HIV Seropositivity
    • HIV Infection
    • poly I-poly C12U
    • Fountain Valley, California
    • +6 more
    Apr 16, 2013

    HIV Trial in Baltimore (Ampligen)

    Completed
    • HIV Infections
    • Ampligen
    • Baltimore, Maryland
      Johns Hopkins Hosp
    Oct 18, 2012